Answers are grounded in this paper and cite their sources.
Background: Infection is a serious complication and a leading cause of death for patients with cancers. The associated risk factors or predictors of antibiotics use in the last week of life in patients with advanced cancers were not clear in Taiwan. Aim: To identify the risk factors or predictors associated with antibiotic uses in advanced cancer patients in the last week of life. Methods: The data were collected retrospectively by reviewing medical records of deceased advanced cancer patients from January 2011 to December 2012 in a regional teaching hospital. Results: Among 417 enrolled subjects, 258 (61.9%) patients received antibiotics. The cephalosporin (29.7%) was the most used. Patients with pneumonia (41.5%) or septicemia (36.8%) accounted for most indications of infection. The significant risk factors or predictors that increased antibiotic uses were fever (OR=229.66, 95% CI: 47.45-4151.10), intensive care unit (ICU) admission (OR=3.11, 95% CI: 1.39-7.30), insertion of nasogastric tube (OR=2.47, 95% CI: 1.39-4.46), urinary catheterization (OR=1.97, 95% CI: 1.08-3.61), comorbidity with cerebral vascular accident (OR=4.65, 95% CI: 1.27-20.49), higher C-reactive protein levels (OR=1.06, 95% CI: 1.02-1.11), and higher white blood cell counts (OR=1.03, 95% CI: 1.01-1.06), but lung cancer patients (OR=0.37, 95% CI: 0.18-0.74) were less likely to use antibiotics. Conclusion: More than one half of patients with advanced cancers received antibiotics in the last week of life. This study revealed that significant risk factors or predictors of antibiotics uses for advanced cancer patients. Further study is needed to examine whether symptoms are improved with antibiotics uses or not.
No takes yet. Share an insight, caveat, or question.
Kao et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: